Today is the day we make a difference
PurpleSun was founded with a singular goal: to transform healthcare. We make an impact by building technologies that harness the power of ultraviolet light to create a sustainable solution for improving quality and preventing Hospital-Acquired Infections.
PurpleSun, The Horizon
PurpleSun is a venture-backed commercial healthcare technology company based out of New York. We are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention.
Our company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care, and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection.
Our goal is to prevent healthcare-acquired infections, which will ultimately save lives, reduce costs, and enhance safety for patients and caregivers. Our clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.
culture
PurpleSun Prepared #PSP A mindfulness that involves a sense of awareness through preparation and perseverance enabling success in an ever-changing environment.
mission
To create the standard for light disinfection technology. We aim to advance the science of FMUV to demonstrate a new paradigm that pushes the boundaries beyond currently acceptable practices, and to become the World’s leading brand in sustainable solutions for quality and infection prevention for patients, staff and hospitals.
vision
Sustainable impact to the quality of care for the healthiest patient-ready environment.
#PSP
2012
Birth of a company that will transform healthcare
Grand Prize WINNERS NYS Business Plan
Named one of the Top 50 most promising startups from around the World
2013
Endorsement from CTO of Health and Human Services
Invited member to the White House CEO Healthcare and Innovation Forum
2012 - 2013
Secured angel investments to move from concept to pre-commercial build
2014
First abstract submitted and published in IDSA 2014, demonstrating superior efficacy with 90-second disinfection cycles
2015
International patent app published w/ strong position
2nd Abstract published w/ successful clinical performance data
2016
Strategic Partnership with Northwell Health, the 12th largest healthcare system in the US
2017
3-month onsite trainings and product design evaluations
Completed Pre-Commercial System
2018
Clinical trials successfully completed
PurpleSun is featured in Wall Street Journal “Game Changers in Health Tech”
American Journal of Infection Control - PurpleSun FMUV Publications
2019
Partnership with Hackensack Meridian
Commercially operational w/ sales team expansion
The Team
-
Luis F. Romo
Founder & CEO -
Dr. Wladyslaw Kowalski
Chief Scientist, World Ultraviolet Expert,
& Co-Founder -
Audrey McNicholas
VP, Operations & Co-Founder -
Ray Dromms
VP, Manufacturing Operations
Clinical Advisors
-
Dr. Thomas Walsh
Director, Infectious Disease Weill Cornell Medicine -
Dr. Vidmantas Petraitis
Assistant Professor of Research in Medicine at Weill Cornell Medicine -
Dr. Ruta Petraitiene
Senior Research Associate in Medicine at Weill Cornell Medicine -
Sal Strods
R&D Advisor Formerly, VP WelchAllyn -
Bill Gruber
Sales and Marketing Advisor CEO, Solace Therapeutics